Association of preconception dysmenorrhea with obstetric complications: the Japan Environment and Children's Study.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
15 Feb 2022
Historique:
received: 22 07 2021
accepted: 17 12 2021
entrez: 16 2 2022
pubmed: 17 2 2022
medline: 24 2 2022
Statut: epublish

Résumé

The association of maternal preconception dysmenorrhea, especially primary dysmenorrhea, with obstetric complications has not been clearly described. Therefore, we evaluated the association of preconception dysmenorrhea with obstetric complications while accounting for the presence of pelvic pathologies. We analyzed the data of women with singleton live births at and after 22 weeks of gestation enrolled in the Japan Environment and Children's Study, a nationwide birth cohort study, between 2011 and 2014. Participants with psychological disorders were excluded. Preconception dysmenorrhea, identified in the medical record transcripts, was categorized into mild dysmenorrhea (MD) and severe dysmenorrhea (SD). Furthermore, excluding those who had pelvic pathologies via self-reported questionnaires (endometriosis, adenomyosis, and uterine myomas) with MD and SD, preconception dysmenorrhea was categorized into mild primary dysmenorrhea (MPD) and severe primary dysmenorrhea (SPD), respectively. Using multiple logistic regression, adjusted odds ratios (aORs) for obstetric complications, including preterm birth (PTB) before 37 weeks and 34 weeks, small-for-gestational-age infants, preterm premature rupture of membrane, and hypertensive disorders of pregnancy, were calculated (considering confounders) in women with (1) MD or SD and (2) MPD or SPD. Women without preconception dysmenorrhea were used as a reference. A total of 80,242 participants were analyzed. In women with SD, the aOR for PTB before 37 weeks was 1.38 (95% confidence interval [CI] 1.10, 1.72). In women with SPD, the aOR for PTB before 37 weeks was 1.32 (95% CI 1.02, 1.71). There was no association between women with MD or MPD and obstetric complications. SD and SPD are significantly associated with an increased incidence of PTB before 37 weeks. Care providers should provide proper counseling regarding the association between preconception dysmenorrhea and obstetric complications. Optimal management of pregnant women with preconception dysmenorrhea to reduce the incidence of PTB should be elucidated in further studies, with detailed clinical data of pelvic pathologies.

Sections du résumé

BACKGROUND BACKGROUND
The association of maternal preconception dysmenorrhea, especially primary dysmenorrhea, with obstetric complications has not been clearly described. Therefore, we evaluated the association of preconception dysmenorrhea with obstetric complications while accounting for the presence of pelvic pathologies.
METHODS METHODS
We analyzed the data of women with singleton live births at and after 22 weeks of gestation enrolled in the Japan Environment and Children's Study, a nationwide birth cohort study, between 2011 and 2014. Participants with psychological disorders were excluded. Preconception dysmenorrhea, identified in the medical record transcripts, was categorized into mild dysmenorrhea (MD) and severe dysmenorrhea (SD). Furthermore, excluding those who had pelvic pathologies via self-reported questionnaires (endometriosis, adenomyosis, and uterine myomas) with MD and SD, preconception dysmenorrhea was categorized into mild primary dysmenorrhea (MPD) and severe primary dysmenorrhea (SPD), respectively. Using multiple logistic regression, adjusted odds ratios (aORs) for obstetric complications, including preterm birth (PTB) before 37 weeks and 34 weeks, small-for-gestational-age infants, preterm premature rupture of membrane, and hypertensive disorders of pregnancy, were calculated (considering confounders) in women with (1) MD or SD and (2) MPD or SPD. Women without preconception dysmenorrhea were used as a reference.
RESULTS RESULTS
A total of 80,242 participants were analyzed. In women with SD, the aOR for PTB before 37 weeks was 1.38 (95% confidence interval [CI] 1.10, 1.72). In women with SPD, the aOR for PTB before 37 weeks was 1.32 (95% CI 1.02, 1.71). There was no association between women with MD or MPD and obstetric complications.
CONCLUSIONS CONCLUSIONS
SD and SPD are significantly associated with an increased incidence of PTB before 37 weeks. Care providers should provide proper counseling regarding the association between preconception dysmenorrhea and obstetric complications. Optimal management of pregnant women with preconception dysmenorrhea to reduce the incidence of PTB should be elucidated in further studies, with detailed clinical data of pelvic pathologies.

Identifiants

pubmed: 35168550
doi: 10.1186/s12884-021-04347-7
pii: 10.1186/s12884-021-04347-7
pmc: PMC8845369
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

125

Investigateurs

Michihiro Kamijima (M)
Shin Yamazaki (S)
Yukihiro Ohya (Y)
Reiko Kishi (R)
Nobuo Yaegashi (N)
Koichi Hashimoto (K)
Chisato Mori (C)
Shuichi Ito (S)
Zentaro Yamagata (Z)
Hidekuni Inadera (H)
Takeo Nakayama (T)
Hiroyasu Iso (H)
Masayuki Shima (M)
Youichi Kurozawa (Y)
Narufumi Suganuma (N)
Koichi Kusuhara (K)
Takahiko Katoh (T)

Informations de copyright

© 2022. The Author(s).

Références

Sci Rep. 2021 Feb 23;11(1):4350
pubmed: 33623113
Hum Reprod Update. 2015 Nov-Dec;21(6):762-78
pubmed: 26346058
J Affect Disord. 2019 Feb 15;245:475-483
pubmed: 30428448
BMJ. 2006 May 13;332(7550):1134-8
pubmed: 16690671
Rocz Akad Med Bialymst. 2004;49:18-21
pubmed: 15631309
Perspect Clin Res. 2015 Jul-Sep;6(3):169-70
pubmed: 26229754
J Matern Fetal Neonatal Med. 2021 Apr 25;:1-7
pubmed: 33899665
PLoS One. 2016 Dec 22;11(12):e0168476
pubmed: 28005934
Fertil Steril. 2012 Jul;98(1):36-40
pubmed: 22658345
J Med Econ. 2013 Nov;16(11):1255-66
pubmed: 24015668
Tohoku J Exp Med. 2018;246(1):27-33
pubmed: 30210086
Pediatr Int. 2014 Oct;56(5):702-8
pubmed: 24617834
Eur J Obstet Gynecol Reprod Biol. 2017 Feb;209:3-7
pubmed: 27216973
J Obstet Gynaecol Res. 2020 Nov;46(11):2292-2297
pubmed: 32808405
Birth. 2020 Sep;47(3):270-277
pubmed: 32500623
Behav Med. 2002 Winter;27(4):179-81
pubmed: 12165972
Am J Epidemiol. 2020 Dec 1;189(12):1583-1589
pubmed: 32601706
Int J Environ Res Public Health. 2021 Feb 24;18(5):
pubmed: 33668326
Int J Methods Psychiatr Res. 2008;17(3):152-8
pubmed: 18763695
Am J Epidemiol. 2015 Oct 15;182(8):730-6
pubmed: 26429998
Fertil Steril. 2017 Oct;108(4):667-672.e5
pubmed: 28874260
J Epidemiol. 2019 May 5;29(5):187-191
pubmed: 30078812
Epidemiol Rev. 2014;36:104-13
pubmed: 24284871
Int J Environ Res Public Health. 2020 Feb 13;17(4):
pubmed: 32069859
Arch Gen Psychiatry. 2010 Oct;67(10):1012-24
pubmed: 20921117
Am J Perinatol. 2007 Jan;24(1):11-6
pubmed: 17094041
PLoS One. 2019 Aug 2;14(8):e0220256
pubmed: 31374085
Pregnancy Hypertens. 2018 Jul;13:291-310
pubmed: 29803330
J Epidemiol. 2016 Aug 5;26(8):420-32
pubmed: 27064130
J Epidemiol. 2018 Feb 5;28(2):99-104
pubmed: 29093304
Acta Obstet Gynecol Scand. 2019 Mar;98(3):359-364
pubmed: 30367455
BMC Public Health. 2014 Jan 10;14:25
pubmed: 24410977

Auteurs

Tsuyoshi Murata (T)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan. tuyoshim@fmu.ac.jp.
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan. tuyoshim@fmu.ac.jp.

Yuta Endo (Y)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Toma Fukuda (T)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Hyo Kyozuka (H)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Shun Yasuda (S)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Akiko Yamaguchi (A)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Akiko Sato (A)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Yuka Ogata (Y)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Kosei Shinoki (K)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Mitsuaki Hosoya (M)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Seiji Yasumura (S)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Department of Public Health, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Koichi Hashimoto (K)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Hidekazu Nishigori (H)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Fukushima Medical Center for Children and Women, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Keiya Fujimori (K)

Fukushima Regional Center for the Japan Environment and Children's Study, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH